New mechanistic therapies for myoglobinuric acute kidney injury

肌红蛋白尿性急性肾损伤的新机制疗法

基本信息

项目摘要

DESCRIPTION (provided by applicant): Our armed forces are routinely exposed to hazardous weapons, pathogens, environmental toxins and, later, medical countermeasures with long-term health effects. The kidney is affected by many toxins metabolized in the body that it excretes, including products of rhabdomyolysis (skeletal muscle degradation), hemolysis, drugs, and exogenous toxins. Many of these compounds cause acute kidney injury (AKI) by producing reactive oxygen species (ROS), which activate apoptotic endonucleases. The resulting acute kidney failure (AKF) is a life-threatening condition that requires hemodialysis or kidney transplantation. This proposal is a continuation of the previous research funded by a VA Merit Review grant. The specific aims in the previous project have been accomplished and the new goals are logical extensions of these aims. The results from the previous study show that the importance of apoptotic endonuclease G (EndoG) in mediating myoglobinuric AKI is much more complex, not limited to DNA fragmentation only, and in some cases, completely opposite to what was initially accepted. The present proposal is based on our recent unexpected observations that myoglobinuric AKI is mediated by apoptotic deoxyribonuclease I (DNase I) regulated by EndoG. Prior to this study, no regulation of an endonuclease by another endonuclease has been described, and EndoG was considered one of the DNA-fragmenting apoptotic endonucleases. Contrary to this, we found that when EndoG becomes activated by later or stronger injury, it inactivates DNase I and thus protects against the injury. Therefore in the kidney, EndoG acts as cytoprotective enzyme instead of being cytotoxic. We hypothesize that myoglobinuric AKI can be prevented by inducing of EndoG-mediated inactivation of DNase I or otherwise inhibiting expression or activity of DNase I before and/or after injury. Our specific objectives are as follows. In Aim 1, we will evaluate native DNase I- and alternatively-spliced DNase I-based therapeutic approaches to ameliorate myoglobinuric tubular cell injury and AKI. In Aim 2, we plan to determine how EndoG-mediated inactivation of DNase I can be used to blunt myoglobunuric AKI. Aim 3 will be using our new high throughput technology to screen chemical library for new DNase I inhibitors applicable for the treatment of myoglobinuric AKI. Potential Impact on Veterans Health Care. Successful completion of these studies can potentially lead to the development of new therapeutic tools to prevent or ameliorate myoglobinuric AKI. Some of them will have strong translational value because they act even if administered after kidney injury, while others can become therapeutic options of the future. When applied to humans, the results of this study may allow saving human lives, improving the health of veterans, and decreasing the number of disabilities in the veteran population.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexei G Basnakian其他文献

Cervical cancer isolate PT3, super-permissive for adeno-associated virus replication, over-expresses DNA polymerase δ, PCNA, RFC and RPA
  • DOI:
    10.1186/1471-2180-9-79
  • 发表时间:
    2009-04-23
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Bum Yong Kang;Hong You;Sarmistha Bandyopadhyay;Nalini Agrawal;Russell B Melchert;Alexei G Basnakian;Yong Liu;Paul L Hermonat
  • 通讯作者:
    Paul L Hermonat

Alexei G Basnakian的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexei G Basnakian', 18)}}的其他基金

BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10589265
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Cellular and Molecular Toxicology Core
细胞和分子毒理学核心
  • 批准号:
    10025389
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Cellular and Molecular Toxicology Core
细胞和分子毒理学核心
  • 批准号:
    10240506
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Cellular and Molecular Toxicology Core
细胞和分子毒理学核心
  • 批准号:
    10487473
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Cellular and Molecular Toxicology Core
细胞和分子毒理学核心
  • 批准号:
    10667650
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
DNase-Targeted Mitigation of Acute Kidney Injury Due to Rhabdomyolysis
DNase 靶向缓解横纹肌溶解引起的急性肾损伤
  • 批准号:
    10292439
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
New mechanistic therapies for myoglobinuric acute kidney injury
肌红蛋白尿性急性肾损伤的新机制疗法
  • 批准号:
    9037502
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
DNase-Targeted Mitigation of Acute Kidney Injury Due to Rhabdomyolysis
DNase 靶向缓解横纹肌溶解引起的急性肾损伤
  • 批准号:
    10043820
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
DNase-Targeted Mitigation of Acute Kidney Injury Due to Rhabdomyolysis
DNase 靶向缓解横纹肌溶解引起的急性肾损伤
  • 批准号:
    10516029
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Novel endonuclease-targeted approaches to nephroprotection
新型核酸内切酶靶向肾保护方法
  • 批准号:
    8391580
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Acute Kidney Failure in a Cancer ICU
癌症 ICU 中的急性肾衰竭
  • 批准号:
    7034020
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
Acute Kidney Failure in a Cancer ICU
癌症 ICU 中的急性肾衰竭
  • 批准号:
    7459945
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
Acute Kidney Failure in a Cancer ICU
癌症 ICU 中的急性肾衰竭
  • 批准号:
    7922716
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
Acute kidney failure: investigation and treatment of ki dney cell injury
急性肾衰竭:肾细胞损伤的调查和治疗
  • 批准号:
    nhmrc : 901011
  • 财政年份:
    1990
  • 资助金额:
    --
  • 项目类别:
    NHMRC Project Grants
Acute kidney failure: new methods of investigation and treatment
急性肾衰竭:研究和治疗的新方法
  • 批准号:
    nhmrc : 891081
  • 财政年份:
    1989
  • 资助金额:
    --
  • 项目类别:
    NHMRC Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了